JP2007537187A5 - - Google Patents

Download PDF

Info

Publication number
JP2007537187A5
JP2007537187A5 JP2007512067A JP2007512067A JP2007537187A5 JP 2007537187 A5 JP2007537187 A5 JP 2007537187A5 JP 2007512067 A JP2007512067 A JP 2007512067A JP 2007512067 A JP2007512067 A JP 2007512067A JP 2007537187 A5 JP2007537187 A5 JP 2007537187A5
Authority
JP
Japan
Prior art keywords
methyl
coo
ethyl
cooh
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007512067A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007537187A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/005027 external-priority patent/WO2005110990A1/de
Publication of JP2007537187A publication Critical patent/JP2007537187A/ja
Publication of JP2007537187A5 publication Critical patent/JP2007537187A5/ja
Pending legal-status Critical Current

Links

JP2007512067A 2004-05-13 2005-05-10 呼吸器疾患の治療においてβアゴニストとして使用するためのヒドロキシ置換ベンゾ縮合ヘテロ環化合物 Pending JP2007537187A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04425342 2004-05-13
PCT/EP2005/005027 WO2005110990A1 (de) 2004-05-13 2005-05-10 Hydroxy-substituierte benzkondensierte heterozyklen als betaagonisten zur behandlung von atemwegserkrankungen

Publications (2)

Publication Number Publication Date
JP2007537187A JP2007537187A (ja) 2007-12-20
JP2007537187A5 true JP2007537187A5 (cg-RX-API-DMAC7.html) 2008-06-26

Family

ID=34932493

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007512067A Pending JP2007537187A (ja) 2004-05-13 2005-05-10 呼吸器疾患の治療においてβアゴニストとして使用するためのヒドロキシ置換ベンゾ縮合ヘテロ環化合物

Country Status (4)

Country Link
EP (1) EP1789394A1 (cg-RX-API-DMAC7.html)
JP (1) JP2007537187A (cg-RX-API-DMAC7.html)
CA (1) CA2565243A1 (cg-RX-API-DMAC7.html)
WO (1) WO2005110990A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004024454A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
RU2442771C2 (ru) 2005-08-08 2012-02-20 Арджента Дискавери Лтд Производные бицикло[2,2,1]гепт-7-иламина и их применения
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
BRPI0807806A2 (pt) * 2007-01-25 2014-06-17 Boehringer Ingelheim Int " processo para a fabricação de beta-miméticos ".
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
CA2679059A1 (en) 2007-02-28 2008-09-04 Cipla Limited Process for preparing isomers of carmoterol
JP2011524896A (ja) 2008-06-18 2011-09-08 アストラゼネカ・アクチエボラーグ 呼吸器障害の処置用のベータ2−アドレナリン受容体アゴニストとして作用するベンズオキサジノン誘導体
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
PL2379507T3 (pl) 2008-12-30 2014-03-31 Pulmagen Therapeutics Inflammation Ltd Związki sulfonamidu do leczenia zaburzeń układu oddechowego
WO2010150014A1 (en) 2009-06-24 2010-12-29 Pulmagen Therapeutics (Inflammation) Limited 5r- 5 -deuterated glitazones for respiratory disease treatment
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
WO2011098746A1 (en) 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
GB201002224D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
GB201002243D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
JO3192B1 (ar) 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
SI2890687T1 (sl) 2012-08-30 2017-10-30 Novartis Ag Soli benzotiazolonske spojine kot agonist beta-2-adrenoceptorja
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
WO2014132205A1 (en) 2013-02-28 2014-09-04 Novartis Ag Formulation comprising benzothiazolone compound
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
CN120583945A (zh) 2023-01-20 2025-09-02 阿托基公司 用于治疗或预防肌肉消耗的β2-肾上腺素能受体激动剂
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses
GB202403169D0 (en) 2024-03-05 2024-04-17 Atrogi Ab New medical uses
WO2025238248A1 (en) 2024-05-17 2025-11-20 Atrogi Ab USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6026784B2 (ja) * 1975-04-29 1985-06-25 樋口 佳成 新規カルボスチリル誘導体
JPS597704B2 (ja) * 1975-05-28 1984-02-20 オオツカセイヤク カブシキガイシヤ カルボスチリルユウドウタイノセイゾウホウ
JPS52283A (en) * 1975-06-23 1977-01-05 Otsuka Pharmaceut Co Ltd Process for preparation of carbostyril derivatives
JPS609713B2 (ja) * 1976-10-08 1985-03-12 大塚製薬株式会社 カルボスチリル誘導体
DE3134590A1 (de) * 1981-09-01 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim Neue benzo-heterocyclen
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4894219A (en) * 1988-03-29 1990-01-16 University Of Florida Beta-agonist carbostyril derivatives, assay method and pharmacological composition
HUP0300832A2 (hu) * 2000-04-27 2003-08-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Új, lassú hatású bétamimetikumok, eljárás előállításukra és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
AR040962A1 (es) * 2002-08-09 2005-04-27 Novartis Ag Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Similar Documents

Publication Publication Date Title
JP2011509916A5 (cg-RX-API-DMAC7.html)
JP2012500245A5 (cg-RX-API-DMAC7.html)
JP2008520742A5 (cg-RX-API-DMAC7.html)
JP2011518811A5 (cg-RX-API-DMAC7.html)
JP2007502806A5 (cg-RX-API-DMAC7.html)
JP2010508296A5 (cg-RX-API-DMAC7.html)
JP2005533868A5 (cg-RX-API-DMAC7.html)
PE20070004A1 (es) Imidazoquinolinas como inhibidores de quinasa de lipido
JP2017515844A5 (cg-RX-API-DMAC7.html)
JP2010521514A5 (cg-RX-API-DMAC7.html)
JP2005537854A5 (cg-RX-API-DMAC7.html)
JP2010509356A5 (cg-RX-API-DMAC7.html)
TW201010990A (en) New combination-408
JP2013540114A5 (cg-RX-API-DMAC7.html)
JP2015520738A5 (cg-RX-API-DMAC7.html)
JP2010526801A5 (cg-RX-API-DMAC7.html)
JP2016511274A5 (cg-RX-API-DMAC7.html)
JP2010521516A5 (cg-RX-API-DMAC7.html)
JP2005500370A5 (cg-RX-API-DMAC7.html)
JP2009501745A5 (cg-RX-API-DMAC7.html)
JP2007515467A5 (cg-RX-API-DMAC7.html)
JP2006516643A5 (cg-RX-API-DMAC7.html)
JP2005538974A5 (cg-RX-API-DMAC7.html)
JP2008520662A5 (cg-RX-API-DMAC7.html)
JP2012501334A5 (cg-RX-API-DMAC7.html)